Answers are grounded in this paper and cite their sources.
Initial expectations that adjuvantation with AS01 could support effective vaccine responses and contribute to disease control have been realized. Investigation of the utility of AS01 in vaccines to prevent other challenging diseases, such as tuberculosis, is ongoing, together with efforts to fully define its mechanisms of action in different vaccine settings.
No takes yet. Share an insight, caveat, or question.
Roman et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: